WNY1613 is a potent and selective PI3Kdelta inhibitor with a piperazinone-containing purine scaffold, exhibiting anti-NHL effects both in vitro and in vivo by inhibiting phosphorylation of downstream components of PI3K in NHL cell lines and inducing apoptosis in cancer cells.
Molecular Weight:
557.65
CAS Number:
[2650546-39-5]
Formula:
C29H35N9O3
Target:
PI3K|||Others|||Apoptosis
T63942
* VAT and and shipping costs not included. Errors and price changes excepted
